Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,170 stories, page 435 of 687

Advanced search

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

ArkBio Completes all Cohort Dosing in Australian Phase I Trial with Influenza AFC Drug AK0406

The Manila TimesOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

China's biotech innovation fuels Merck's long-term healthcare bet

China Daily Global EditionOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Dimerix Secures $10 Million for Its Phase 3 Kidney Trial—and Adds a New Asset

KalkineOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Multiple Logics Reshaping: China's Pharmaceutical Industry Enters a Critical Phase of 'Strategic Stalemate'

MoomooOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

South Korea accelerates mRNA vaccine push as GC Biopharma seeks phase 2 - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Nascent Biotech Inc. – OTC:NBIO

TradingViewOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

ArkBio Completes all Cohort Dosing in Australian Phase I Trial with Influenza AFC Drug AK0406

google_newsOriginal source

🌍Jul 24discoverynews.google.comTier 2 · Trade media

FDA panel endorses broader use of certain peptides

BioPharma DiveOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

WATCH: FDA advisory panel recommends easing access to 6 out of 7 popular peptides

PBSOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

CT ENTERPRISE Rebrands as CPBIO: Company completes transition to a biotech-driven business, positioning itself as an integrated life sciences platform

TradingViewOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Ltd (TEVA) Stock Up 3.4% but GF V

GuruFocusOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech, Inc.(NasdaqGS: KRYS) added to S&P 400 - Biotechnology

marketscreener.comOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech, Inc.(NasdaqGS: KRYS) added to S&P 400 Health Care

marketscreener.comOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech, Inc.(NasdaqGS: KRYS) dropped from S&P 600 Health Care

marketscreener.comOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech, Inc.(NasdaqGS: KRYS) dropped from S&P 600

marketscreener.comOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene plunges as US phase 3 fails; Korea investors brace for fallout - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Boston biotech company creates perfumes inspired by extinct flowers and clouds

WCVBOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

'Not scientifically supportable:' Inside FDA’s refusal to face US generic drug crisis

WOAIOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Neuren Pharmaceuticals Advances Phase 3 Koala Trial for Phelan-McDermid Syndrome as Presenting Sponsor of Family Conference

KalkineOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

KDCA Submits Phase 2 IND for Domestic mRNA COVID-19 Vaccine

아시아경제Original source

🇺🇸Jul 24Regulatorysec.govTier 1 · Regulatory source

GSK filed Form 6-K

SEC EDGAROriginal source

🇫🇷Jul 24Industrysanofi.comTier 1 · Company source

2026 07 24 05 30 00 3332696

Sanofi today announced discontinuation of clinical development of amlitelimab, an OX40-ligand monocl...

Sanofi NewsOriginal source

🇺🇸Jul 24Industrygilead.comTier 1 · Company source

CHMP Recommends Gilead’s Trodelvy® Plus Keytruda® in PD-(L)1-Positive First-Line Metastatic Triple-Negative Breast Cancer

Gilead SciencesOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Proposed Collection; Comment Request

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to co...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Submission for OMB Review; Comment Request

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to co...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

HHS Request for Comment on the Update to the National Plan To Address Alzheimer's Disease

HHS released the first National Plan to Address Alzheimer's Disease in 2012, establishing a comprehe...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Proposed Information Collection Activity; Voluntary Acknowledgment of Paternity and Required Data Elements for Paternity Establishment Affidavits

The Office of Child Support Enforcement (OCSE), Administration for Children and Families (ACF), U.S....

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Evonik Corporation, Filing of Food Additive Petition (Animal Use)

The Food and Drug Administration (FDA or we) is announcing that we have filed a food additive petiti...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Biologics License Application (BLA) 125827, From Replimune, Inc. for Vusolimogene Oderparepvec

The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Ce...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Cellular, Tissue, and Gene Therapies Advisory Committee; Amendment of Notice-Biologics License Application (BLA) 125842 From Capricor, Inc. for Deramiocel (Human Allogeneic Cardiosphere-Derived Cells)

The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Ce...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Rescinding Portions of the U.S. Department of Health and Human Services Title VI Regulations To Align With the Statutory Text and Conform to Executive Order 14281

By this rule, the U.S. Department of Health and Human Services amends its regulations implementing T...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Francis Esteban Matos: Final Debarment Order

The Food and Drug Administration (FDA or the Agency) is issuing an order under the Federal Food, Dru...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; Orthopedic Devices; Classification of the Intraoperative Surgical Angle Measurement Tool

The Food and Drug Administration (FDA) is classifying the intraoperative surgical angle measurement...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; General Hospital and Personal Use Devices; Classification of the Diabetes Digital Behavioral Therapeutic Device

The Food and Drug Administration (FDA) is classifying the diabetes digital behavioral therapeutic de...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; Immunology and Microbiology Devices; Classification of the Over-the-Counter Test To Detect SARS-CoV-2 From Clinical Specimens

The Food and Drug Administration (FDA) is classifying the over-the-counter test to detect SARS-CoV-2...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Prognostic Test for Assessment of Chronic Kidney Disease Progression

The Food and Drug Administration (FDA) is classifying the prognostic test for assessment of chronic...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Government Owned Invention Available for License: Nucleophosmin 1 (NPM1) Mutation-Specific T Cell Receptors for Targeted Treatment of Acute Myeloid Leukemia (AML)

The NCI seeks research co-development partners or licensees for NPM1 Mutation-Specific T Cell Recept...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Government Owned Invention Available for License: Pigment Epithelium-Derived Factor Peptides and Their Use for Treating Retinal Degeneration

The National Eye Institute (NEI) seeks research co-development partners and/or licensees for the dev...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Government-Owned Inventions; Availability for Licensing

The National Institute of Allergy and Infectious Diseases (NIAID), an institute of the National Inst...

Federal RegisterOriginal source

🇺🇸Jul 24Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Notice of Closed Meeting

Federal RegisterOriginal source

🇹🇭Jul 24Regulatoryfda.moph.go.thTier 1 · Regulatory source

24 ก.ค. 69อย. แท็กทีม 11 องค์กร คิกออฟ ยกระดับอาหารอนาคตไทย ผ่านระบบบัญชี Positive list หนุน SMEs แข่งขันระดับสากลอ่านเพิ่มเติม →

อย. ผนึกกำลัง 11 หน่วยงาน ทั้งภาครัฐและเอกชน ผลักดันระบบบัญชี Positive list การันตีความปลอดภัยและประ...

Thai FDAOriginal source

🇹🇭Jul 24Regulatoryfda.moph.go.thTier 1 · Regulatory source

24 ก.ค. 69อย. เดินหน้าขับเคลื่อน “ทางเลือกสุขภาพ” ติวเข้มผู้ประกอบการทั่วประเทศ มุ่งเพิ่มผลิตภัณฑ์สุขภาพ สร้างทางเลือกที่ดี ลดเสี่ยง NCDs อย่างยั่งยืนอ่านเพิ่มเติม →

อย. ติวเข้มผู้ประกอบการเพื่อส่งเสริมความรู้ความเข้าใจหลักเกณฑ์ของสารอาหารและคุณค่าทางโภชนาการที่ใช้พ...

Thai FDAOriginal source

🇺🇰Jul 24Industryastrazeneca.comTier 1 · Company source

Trixeo recommended for approval in the EU by CHMP for the maintenance treatment of asthma

AstraZeneca NewsOriginal source

🇺🇰Jul 24Industryastrazeneca.comTier 1 · Company source

Enhertu plus pertuzumab recommended for approval in the EU by CHMP as 1st-line treatment for patients with HER2-positive metastatic breast cancer

AstraZeneca NewsOriginal source

🇪🇸Jul 24Industryalmirall.comTier 1 · Company source

Almirall and Certest Biotec announce research collaboration and licensing agreement

Almirall (Global)Original source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Development and Maintenance of Human and Animal Food Rapid Response Teams

Recipient: MISSOURI STATE DEPT/ HEALTH & SENIOR SRV. Award amount: 168750.

NIH RePORTEROriginal source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: RRT Maintenance Pennsylvania Department of Agriculture (PDA)

Recipient: PENNSYLVANIA DEPARTMENT OF AGRICULTURE. Award amount: 240000.

NIH RePORTEROriginal source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Expanding Minnesota's Rapid Response Team through Outreach, Engagement, and Enhancements

Recipient: MINNESOTA STATE DEPT OF AGRICULTURE. Award amount: 225000.

NIH RePORTEROriginal source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: California Rapid Response Team 2023-2026 (CalFERT) - maintenance

Recipient: CALIFORNIA DEPARTMENT OF PUBLIC HEALTH. Award amount: 223322.

NIH RePORTEROriginal source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT)

Recipient: UNIVERSITY OF MELBOURNE. Award amount: 400977.

NIH RePORTEROriginal source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Endocrine-mediated pubertal brain network development: Bridging datasets with machine learning

Recipient: FLORIDA INTERNATIONAL UNIVERSITY. Award amount: 224100.

NIH RePORTEROriginal source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Administrative Core

Recipient: JOHNS HOPKINS UNIVERSITY. Award amount: 499447.

NIH RePORTEROriginal source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Center to Accelerate Translation of Interventions to Decrease Premature Mortality in Persons with Serious Mental Illness

Recipient: JOHNS HOPKINS UNIVERSITY. Award amount: 2454379.

NIH RePORTEROriginal source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: MutSensor System: A Set of Highly Sensitive Mutation Reporters to Dissect Genome Stability in Health and Disease

Recipient: NEW YORK UNIVERSITY SCHOOL OF MEDICINE. Award amount: 743249.

NIH RePORTEROriginal source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Pathology Core

Recipient: JOHNS HOPKINS UNIVERSITY. Award amount: 150164.

NIH RePORTEROriginal source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Multidisciplinary approach to study of patients with Severe Alcoholic Hepatitis Undergoing Liver Transplantation

Recipient: JOHNS HOPKINS UNIVERSITY. Award amount: 1694816.

NIH RePORTEROriginal source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Flow Cytometry Human Immune Monitoring Shared Resource

Recipient: THOMAS JEFFERSON UNIVERSITY. Award amount: 1.

NIH RePORTEROriginal source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: BioImaging Shared Resource

Recipient: THOMAS JEFFERSON UNIVERSITY. Award amount: 1.

NIH RePORTEROriginal source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Biostatistics, Bioinformatics, and Research Informatics Shared Resource

Recipient: THOMAS JEFFERSON UNIVERSITY. Award amount: 1.

NIH RePORTEROriginal source

🇺🇸Jul 24Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Clinical Protocol and Data Management

Recipient: THOMAS JEFFERSON UNIVERSITY. Award amount: 463341.

NIH RePORTEROriginal source